Escherichia coli

Related records

Trials (15)

• A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
• A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
• A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
• A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
• A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
• A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
• A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
• Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
• Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
• Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
• Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
• Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)
• The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
• The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
• The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia